+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Glycemic control before and after starting insulin therapy in obese and other type 2 diabetics

Glycemic control before and after starting insulin therapy in obese and other type 2 diabetics

Diabetologia Croatica 35(3): 59-62

Type 2 diabetes mellitus is a chronic progressive disease slowly reaching a pandemic extent. Its prevalence is growing in the younger population, probably due to the epidemic of obesity. Numerous clinical and randomized studies have shown that morbidity and mortality due to chronic complications are decreased significantly by good glycemic control. The aim of our stud), was to assess the glycemic control in patients prior to starting insulin therapy and to establish the extent to which glycated hemoglobin (HbA(lc)) level decreased upon the introduction of therapy in patients grouped according to their body mass index. According to the American Diabetes Association (ADA) and International Diabetic Federation (IDF) guidelines, HbA(lc) was too high prior to insulin therapy All patients, i.e. those with normal body weight and overweight, benefited from insulin therapy. The introduction of insulin therapy resulted in a statistically significant decrease in HbA(lc) level and less new microvascular complications. A more rapid recruiting of patients for insulin therapy would significantly decrease the respective morbidity and mortality rates, and serve to approach glycemic control in accordance with ADA and IDF guidelines.

(PDF emailed within 1 workday: $29.90)

Accession: 013247196

Download citation: RISBibTeXText

Related references

Changes in glycemic control and quality of life in pediatric type 1 diabetics with continuous subcutaneous insulin infusion of insulin aspart following multiple daily injection therapy. Clinical Pediatric Endocrinology 17(2): 39-47, 2008

Assessment of glycemic control by continuous glucose monitoring system in 50 children with type 1 diabetes starting on insulin pump therapy. Pediatric Diabetes 5(3): 117-121, 2004

Does bromocriptine improve glycemic control of obese type-2 diabetics?. Hormone Research 62(2): 55-59, 2004

Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes. Journal of Diabetes and Its Complications 23(2): 143-152, 2008

Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes. Diabetes Care 21(9): 1575-1575, 1998

Bromocriptine improves glycemic control in type 2 diabetics on insulin. Diabetes 48(SUPPL 1): A99, 1999

Insulin receptor interaction beta cell function insulin requirements glycemic control and serum lipids in insulin dependent diabetics and non insulin dependent diabetics treated with guar gum. Diabetes Research & Clinical Practice (SUPPL 1): S199, 1985

Effect of improved glycemic control by continuous subcutaneous insulin infusion on hormonal responses to insulin-induced hypoglycemia in type 1 diabetics. Acta Medica Scandinavica 218(1): 111-118, 1985

Biphasic insulin aspart 30: better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes. Journal of Endocrinological Investigation 32(1): 23-27, 2009

Effect of glipizide on glycemic control and peripheral insulin sensitivity in type 1 diabetics. Diabete & Metabolisme 16(2): 93-97, 1990

Study suggests drug significantly improves glycemic control in type 1 diabetics on insulin. 2011

Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics. Journal of Clinical Endocrinology and Metabolism 54(2): 217-222, 1982

Severe hypoglycemia rates and associated costs among type 2 diabetics starting basal insulin therapy in the United States. Current Medical Research and Opinion 30(10): 1991-2000, 2015

Glycemic control with regular versus lispro insulin sliding scales in hospitalized Type 2 diabetics. Journal of Diabetes and Its Complications 20(3): 153-157, 2006